Transplant International

Papers
(The TQCC of Transplant International is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics68
A systematic review and meta‐analyses of regional perfusion in donation after circulatory death solid organ transplantation64
Consensus statement on normothermic regional perfusion in donation after circulatory death: Report from the European Society for Organ Transplantation’s Transplant Learning Journey52
The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient – One year into the pandemic39
Donor‐derived cell‐free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta‐analysis35
Treatment of transplant kidneys during machine perfusion33
SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know32
Generation of insulin‐secreting organoids: a step toward engineering and transplanting the bioartificial pancreas32
Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score31
Recovery of kidney function after AKI because of COVID‐19 in kidney transplant recipients28
Organ utilization – the next hurdle in transplantation?27
eHealth in transplantation26
Stratifying the humoral risk of candidates to a solid organ transplantation: a proposal of the ENGAGE working group26
Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond26
Magnetic resonance imaging assessment of renal flow distribution patterns during ex vivo normothermic machine perfusion in porcine and human kidneys24
COVID‐19 and education: restructuring after the pandemic23
Machine learning in liver transplantation: a tool for some unsolved questions?23
Abstracts23
Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients22
Organoid transplant approaches for the liver22
Human liver stem cell‐derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia22
Exploring the causes of the high incidence of delayed graft function after kidney transplantation in Brazil: a multicenter study20
Clinical outcomes associated with computed tomography‐based body composition measures in lung transplantation: a systematic review20
Association of graft survival with tacrolimus exposure and late intra‐patient tacrolimus variability in pediatric and young adult renal transplant recipients—an international CTS registry analysis19
Simultaneous liver kidney allocation policy and the Safety Net: an early examination of utilization and outcomes in the United States19
Kidney transplant recipient perspectives on telehealth during the COVID‐19 pandemic18
Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation — a retrospective single‐center cohort study18
Successful pancreas allotransplantations after hypothermic machine perfusion in a novel diabetic porcine model: a controlled study17
A retrospective single‐centre analysis of the oncological impact of LI‐RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule matters17
Undoubtedly, kidney transplant recipients have a higher mortality due to COVID‐19 disease compared to the general population16
The effects of exercise training in adult solid organ transplant recipients: A systematic review and meta‐analysis15
EBV‐specific cytotoxic T lymphocytes for refractory EBV‐associated post‐transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review15
A 2020 Banff Antibody‐mediatedInjury Working Group examination of international practices for diagnosing antibody‐mediated rejection in kidney transplantation – a cohort study15
Kidney exchange strategies: new aspects and applications with a focus on deceased donor‐initiated chains15
Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index, and the Balance of Risk score on graft loss after liver transplantation14
Long‐term outcome after hand and forearm transplantation – a retrospective study14
Disease‐specific waitlist outcomes in liver transplantation – a retrospective study14
Cellular therapies in organ transplantation14
Trends in indications and outcomes of liver transplantation in Canada: A multicenter retrospective study13
Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients13
Successful 18‐h acellular extracorporeal perfusion and replantation of porcine limbs ‐ Histology versus nerve stimulation13
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases13
Early intestinal complications following pancreas transplantation: lessons learned from over 300 cases – a retrospective single‐center study13
Full‐left‐full‐right split liver transplantation for adult recipients: a systematic review and meta‐analysis13
Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation13
ABO‐incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity‐matched analysis12
Solid organ transplantation is not a risk factor for COVID‐19 disease outcome12
Proteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1‐year outcome12
Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation12
Safe use of right lobe living donor livers with moderate steatosis in adult‐to‐adult living donor liver transplantation: a retrospective study12
Considering extended right lobe grafts as major extended donor criteria in liver transplantation is justified12
An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan12
Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation12
Clinical value and limitations of the preoperative C‐reactive‐protein‐to‐albumin ratio in predicting post‐operative morbidity and mortality after deceased‐donor liver transplantation: a retrospective 11
Have we reached the limits in altruistic kidney donation?11
Successful liver transplantation immediately after recovery from COVID‐19 in a highly endemic area11
Assessment of the global practice of living donor liver transplantation11
The impact of functional delayed graft function in the modern era of kidney transplantation – A retrospective study11
Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha‐fetoprotein score: a new prognostic risk factor11
Impact of belatacept conversion on kidney transplant function, histology, and gene expression ‐ a single‐center study11
The evolution of histological changes suggestive of antibody‐mediated injury, in the presence and absence of donor‐specific anti‐HLA antibodies11
Center volume and primary graft dysfunction in patients undergoing lung transplantation in the United States – a cohort study11
Regulatory B cells in transplantation: roadmaps to clinic11
Organ transplants of the future: planning for innovations including xenotransplantation11
A systematic review and meta‐analysis on the incidence of osteoporosis and fractures after liver transplant11
De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody‐mediated rejection after liver transplantation – a retrospective study11
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐makin11
Guiding therapeutic plasma exchange for antibody‐mediated rejection treatment in lung transplant recipients – a retrospective study10
Influence of donor‐transmitted coronary artery disease on long‐term outcomes after heart transplantation ‐ a retrospective study10
Editorial: changing of the guard at Transplant International10
Development of ex situ normothermic reperfusion as an innovative method to assess pancreases after preservation10
Cell therapy during machine perfusion10
Addressing ethical confusion in deceased donation and transplantation research: the need for dedicated guidance10
Hypothermic oxygenated machine perfusion of the human pancreas for clinical islet isolation: a prospective feasibility study10
Impact of coronavirus disease 2019 on organ donation and transplantation in France10
Mini‐organs forum: how to advance organoid technology to organ transplant community10
US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?10
COVID‐19 among kidney‐transplant recipients requiring hospitalization: preliminary data and outcomes from a single‐center in Brazil10
Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution10
Impact of unilateral diaphragm elevation on postoperative outcomes in bilateral lung transplantation – a retrospective single‐center study10
Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits10
Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV‐associated nephropathy10
Impact on biliary complications of donor abdominal aortic calcification among living donor liver transplantation: a retrospective study10
Pre‐transplant donor‐specific HLA antibodies and risk for poor first‐year renal transplant outcomes: results from the Swiss Transplant Cohort Study9
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation9
Utilization of extracorporeal membrane oxygenation in DCD and DBD lung transplants: a 2‐year single‐center experience9
Conditional probability of graft survival in liver transplantation using donation after circulatory death grafts – a retrospective study9
Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti‐thymocyte globulin without CMV prophylaxis –9
Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: a systematic review and network meta‐analysis9
Health‐related quality of life, uncertainty and coping strategies in solid organ transplant recipients during shielding for the COVID‐19 pandemic9
COVID‐19 in lung transplant recipients: an overview of the Swedish national experience9
Short‐ and long‐term results of liver transplantation according to age at transplant: a single‐center experience of 351 children9
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis9
Graft utilization after normothermic regional perfusion in controlled donation after circulatory death—a single‐center perspective from France9
Safety and efficacy of direct oral anticoagulants under long‐term immunosuppressive therapy after liver, kidney and pancreas transplantation9
Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta‐analysis9
Global kidney exchange should expand wisely9
Anti‐HLA and anti‐SARS‐CoV‐2 antibodies in kidney transplant recipients with COVID‐199
Pancreas utilization rates in the UK – an 11‐year analysis9
Non‐simultaneous kidney exchange cycles in resource‐restricted countries without non‐directed donation – a prospective single‐center cohort study9
Application of ischaemia‐free liver transplantation improves prognosis of patients with steatotic donor livers – a retrospective study8
Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study8
Pancreas collagen digestion during islet of Langerhans isolation—a prospective study8
Outcomes with alemtuzumab induction therapy in lung transplantation: a comprehensive large‐scale single‐center analysis8
Liver transplantation for congenital hepatic fibrosis8
Association between procurement biopsy findings and deceased donor kidney outcomes: a paired kidney analysis8
Assessment of the Banff Working Group classification of definitive BK polyomavirus nephropathy8
Safety of intra‐operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score‐matched survival analysis8
Sequential genetic testing of living‐related donors for inherited renal disease to promote informed choice and enhance safety of living donation8
Cancer transmissions and non‐transmissions from solid organ transplantation in an Australian cohort of deceased and living organ donors8
Lung transplantation from uncontrolled and controlled donation after circulatory death: similar outcomes to brain death donors8
Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis8
Correcting anemia and native vitamin D supplementation in kidney transplant recipients: a multicenter, 2 × 2 factorial, open‐label, randomized clinical trial8
The real incidence of biliary tract complications after adult liver transplantation: the role of the prospective routine use of cholangiography during post‐transplant follow‐up8
Metabolic outcomes and renal function after simultaneous kidney/pancreas transplantation compared with kidney transplantation alone for type 2 diabetes mellitus patients8
0.048523902893066